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ABSTRACT 
Mushrooms are an important source of natural compounds with acknowledged bioactivity. 
Pleurotus eryngii (DC.) Quél., in particular, is widely recognized for its organoleptic quality 
and favorable health effects, being commercially produced in great extent. On the other hand, 
Suillus bellinii (Inzenga) Watling is an ectomycorrhizal symbiont, whose main properties 
were only reported in a scarce number of publications. Some current trends point toward 
using the mycelia and the culture media as potential sources of bioactive compounds, in 
addition to the fruiting bodies. Accordingly, P. eryngii and S. bellinii were studied for their 
composition in phenolic acids and sterols, antioxidant capacity (scavenging DPPH radicals, 
reducing power, β-carotene bleaching inhibition and TBARS formation inhibition), anti-
inflammatory effect (by down-regulating LPS-stimulated NO in RAW264.7 cells) and anti-
proliferative activity (using MCF-7, NCI-H460, HeLa, HepG2 and PLP2 cell lines). Overall, 
S. bellinii mycelia showed higher contents of ergosterol and phenolic compounds (which were 
also detected in higher quantity in its fruiting body) and stronger antioxidant activity than P. 
eryngii. On the other hand, P. eryngii mycelia showed anti-inflammatory (absent in S. bellinii 
mycelia) and a cytotoxicity similar (sometimes superior) to its fruiting bodies, in opposition to 
S. bellinii, whose mycelia presented a decreased anti-proliferative activity. Furthermore, the 
assayed species showed differences in the growth rate and yielded biomass of their mycelia, 
which should also be considered in further applications. 
 
Keywords: Pleurotus eryngii (DC.) Quél., Suillus bellinii (Inzenga) Watling, ergosterol, 
phenolic acids, antioxidant activity, anti-inflammatory activity, anti-proliferative activity. 
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RESUMO 
Os cogumelos são uma importante fonte de compostos naturais com reconhecida bioatividade. 
Pleurotus eryngii (DC.) Quél., em particular, é largamente reconhecido pela sua qualidade 
organolética e benefícios para a saúde, sendo comercialmente produzido em larga escala. 
Por outro lado, Suillus bellinii (Inzenga) Watling é um fungo simbionte ectomicorrízico, cujas 
propriedades estão pouco documentadas. A produção de micélio através da cultura in vitro 
revela-se como uma fonte potencial de obtenção de compostos bioativos, para além da 
produção pelos carpóforos. Assim sendo, P. eryngii e S. bellinii foram estudados na sua 
composição em ácidos fenólicos e esteróis, capacidade antioxidante (capacidade de captação 
de radicais de DPPH; poder redutor, inibição do branqueamento do β-caroteno e Inibição da 
formação de TBARS), capacidade anti-inflamatória (através da regulação negativa da NO 
estimulada pela LPS na linha celular RAW264.7) e a atividade anti-proliferativa (nas linhas 
celulares MCF-7, NCI-H460, HeLa, HepG2 e PLP2). O micélio de S. bellinii mostrou 
maiores conteúdos de ergosteral e de compostos fenólicos (que também foram detetados em 
maiores quantidades). 
Por outro lado, o micélio de P. eryngii apresentou capacidade anti-inflamatória e 
citotoxicidade similares (e por vezes superiores) ao corpo frutífero, ao contrário do que 
acontece com S. bellinii, cujo micélio apresenta uma atividade anti-proliferativa diminuída. 
Além disso, as espécies estudadas apresentam diferenças nas taxas de crescimento e de 
produção de biomassa dos seus micélios, que tem que ser considerada em futuras aplicações. 
 
Palavras-chave: Pleurotus eryngii (DC.) Quél., Suillus bellinii (Inzenga) Watling, ergosterol, 
acidos fenólicos, atividade antioxidante, atividade anti-inflamatória, atividade anti-
proliferativa.  
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CHAPTER 1. FRAMEWORK 
The number of mushroom species on earth is evaluated to be 140.000, proposing that only 
10% are already known (Ferreira et al., 2010).  
For several centuries, wild mushrooms have been part of the normal human diet, and also 
extensively consumed due to their organoleptic properties including distinctive flavor, texture, 
and taste. Edible wild mushrooms have been described as source of chemical and nutritional 
properties. They are rich in minerals, water (80 to 90%), protein, fiber and vitamins (thiamine, 
riboflavin, ascorbic acid, vitamin D2, and carbohydrates). They are low caloric foods due to 
low lipids level (free fatty acids, mono-, di- and triglycerides, sterols, and phospholipids) 
(Heleno et al., 2009; Kalac, 2009, 2012). Beyond the nutritional characteristics, several 
medicinal properties have been reported, mainly due to their richness in bioactive compounds, 
secondary metabolites, including phenolic compounds (Carocho & Ferreira, 2013), 
polysaccharides (Ren et al., 2016), and lipids (Heleno et al., 2009), that present antioxidant 
(Ferreira et al., 2009), antitumor (Ferreira el al., 2010), anti-inflammatory (Taofiq et al., 
2015), antibacterial (Alves et al., 2012) and antifungal (Alves et al., 2013) properties, among 
other bioactivities.  
Not just fruiting bodies, also their mycelium has been recognized as a source of natural new 
drugs. In this context, mushroom mycelium is produced through novel biotechnologies in 
order to produce bioactive compounds using as pharmaceutical agent or functional food (Reis 
et al., 2011). 
This work deals the production of mushroom mycelium for food drugs, using different solid 
and liquid culture media. Furthermore, to contribute to the knowledge of bioactivity of 
phenolic acids and ergosterol extract obtained from fruiting bodies, mycelium and culture 
media of two species Pleurotus eryngii and Suillus bellinii. 
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CHAPTER 2.  INTRODUCTION 
1. Studied mushroom species 
1.1  Pleurotus eryngii (DC.) Quél. 
The genus Pleurotus (Fries) Kummer was defined by Paul Kummer in 1871 and belongs to 
the phylum Basidiomycota and the order Agaricales. Many of the species of this genus 
produce mushroom that usually live in wood and grow in clusters. They have a range of 
spores varying from white to pink, brown, and nearly black (Trudell & Ammirati, 2009). 
 
 
 
 
 
 
Figure 1.  Fruiting body of Pleurotus eryngii (DC.) Quél. 
This group of mushrooms can be recognized by its rather soft and fleshy fruiting body (Arora, 
1986). It exhibits a short-term growth compared to other mushrooms (Liu et al., 2016), it has a 
high nutritional value and several therapeutic properties, being also used in different 
biotechnological and environmental applications (Knop et al., 2015; Corrêa et al., 2016).  
Pleurotus eryngii (DC.) Quél. is a widespread species in the Mediterranean, central Europe, 
central Asia, and North Africa. It has a convex cap and very decurrent whitish gills (Figure 
1). It is a weak parasite, and can live on the root or stem base of plants. P. eryngii taxon is 
described as ‘complex’ due to the significant variations in morphology, biochemical and 
genetic makeup so it has a wide geographical distribution. It is also used in biotechnological 
processes including food production, bioremediation of soil and industrial waters, 
biotransformation of raw plant materials to feed, among others (Stajic et al., 2009; Reis et al., 
2014).   
Additionally, it has a high nutritional value, so the commercial production of this species has, 
in the last few decades, increased rapidly worldwide. The nutritional value of P. eryngii 
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reported by Reis et al., (2014) was as follows: moisture (82.59±0.36 g/100 g fw), ash 
(14.95±0.91 g/100 g dw), proteins (2.09±0.01 g/100 g dw) and energy (362.00±2.06 kcal/100 
g dw); its free sugars were mannitol (1.40±0.09 g/100 g dw) and trehalose (14.21±0.23 g/100 
g dw), and tocopherols included α-tocopherol (6.79±1.80 μg/100 g dw), β-tocopherol 
(48.24±9.53 μg/100 g dw) and γ-tocopherol (31.55±7.56 μg/100 g dw). It presented low levels 
of fatty acids being the major ones palmitic acid (17.44±0.21%), stearic acid (4.77±0.08%), 
oleic acid (47.52±0.07%) and linoleic acid (24.71±0.28%). The percentages of saturated, 
monounsaturated and polyunsaturated fatty acids were 25.79±0.18%, 49.05±0.24% and 
25.17±0.24%, respectively (Reis et al., 2014). The main organic acids found in P. eryngii 
were oxalic acid (2.02±0.03 mg/g dw), malic acid (18.48±0.07 mg/g dw), citric acid 
(28.73±0.57 mg/g dw) and fumaric acid (2.50±0.05 mg/g dw) (Barros et al., 2013). 
P. eryngii is esteemed primarily for its nutritional value, but it can also have bioactive 
properties through different active substances such as polysaccharides, lipids, peptides, 
sterols, dietary fibers, etc. Furthermore, several recent studies have indicated that P. eryngii 
polysaccharides have several functions, including hepatoprotector, immunity enhancer and 
antihyperlipidemia, and can inhibit the growth of several types of tumor cell lines (Ren et al., 
2016). 
1.2  Suillus bellinii (Inzenga) Watling 
The genus Suillus (Inzenga) Watling is equivalent to the Boletaceae (Hawksworth et al., 
1995); it is a genus from the phylum Basidiomycota and order Agaricales (Arora, 1986).  
The fruiting bodies are yellow, brown and reddish in many species of the genus (Trudell & 
Ammirati, 2009). In addition, Arora, (1986) illustrated that the genus Suillus has a “slippery” 
cap, the pores are radially elongated in some species, having a veil or a glandular-dotted stem 
or both, and being mycorrhizal almost exclusively with conifers. Furthermore, Suillus spp. is 
considered C-demanding species able to produce large amounts of biomass and produce large 
amounts of exudates (Izumi et al., 2013). 
Suilus bellinii (Inzenga) Watling is known as an ectomycorrhizal symbiont associated with a 
wide range of plant hosts (Figure 2) (Franco & Castro, 2015). 
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Figure 2.  Fruiting body of Suillus bellinii (Inzenga) Watling 
Suillus bellinii  has different organic acids such as malic acid, quinic acid (31.2±1.37 g/kg 
dw); 42% of nonaromatic acids; citric acid (11.2±0.27 g/kg dw); 20% of nonaromatic acids 
and also fatty acids, mainly palmitic acid (160.702 mg/kg dw) (Ribeiro et al., 2009). 
S. bellinii is also rich in alcohols, which are considered to be the main odorants of the 
mushroom like aroma (Guedes De Pinho et al., 2008).  
2. Bioactive compound in wild mushrooms 
Mushrooms have become attractive as functional foods and as a source of physiologically 
beneficial bioactive compounds. Herein, we will give emphasis to phenolic acids and 
ergosterol.  
2.1  Phenolic acids 
Phenolic compounds represent about 8000 different phenolic structures. They have one or 
more aromatic rings with one or more hydroxyl groups, including different subclasses such as 
flavonoids, phenolic acids, stilbenes, lignans, tannins, and oxidized polyphenols (Crozier et 
al., 2006; Barros et al., 2009; Fraga et al., 2010; Carocho & Ferreira, 2013). Table 1 displays 
their structure as well as the number of carbons and representative compounds. 
They are secondary metabolites that have an important role in health-promoting and 
nutraceutical potential of mushrooms in food (Chan et al., 2014; Tulio et al., 2014). The 
content of these compounds is highly correlated with the antioxidant activity of mushrooms 
and thus can be used as the important determinant in evaluating free radicals and scavenging 
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potential of the mushroom extracts (Chan et al., 2011; Bertalanic et al., 2012; Skotti et al., 
2014). 
Table1.  Classification through number of carbons and basic structure of molecules within the phenolic 
compounds family (Carocho & Ferreira, 2013). 
Number of carbons Classification Example Basic structure 
7 Hydroxybenzoic acids Gallic acid  
9 Hydroxycinnamic acids p-Coumaric acid 
  
9 Coumarins Esculetin 
  
13 Xanthons Mangiferin 
 
14 Stilbenes Resveratrol 
  
15 Flavonoids Naringenin 
 
Several research studies have reported the bioactive potential of phenolic acids as the main 
phenolic compounds found in mushroom, as well their quantity was commonly determined by 
HPLC (High performance Liquid Chromatograhy) (Ferreira et al., 2009; Heleno et al., 2015). 
Phenolic acids can be splitted into two major categories, hydroxybenzoic acids and 
hydroxycinnamic acids, which are derived from non-phenolic molecules of benzoic and 
cinnamic acid, respectively. These compounds have at least one aromatic ring in which at 
least one hydrogen is substituted by a hydroxyl group (Figure 3) (Heleno et al., 2014). 
Hydroxybenzoic acid derivatives occur in the bound form and are typically a component of a 
complex structure like lignins and hydrolyzable tannins. They can also be found associated to 
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sugars or organic acids in plant foods. Hydroxycinnamic acid derivatives are present in the 
bound form, linked to cell-wall structural components, including cellulose, lignin, and protein, 
as well as linked to organic acids (Ferreira et al., 2009).  
Phenolic acids are synthesized from the shikimate pathway from L-phenylalanine or L- 
tyrosine (Rice-Evans et al., 1996) (Figure 4). These amino acids are the common precursors 
of the majority of the phenolic natural products. 
 
 
 
 
 
 
 
 
 
Figure 3. Chemical structures of benzoic and cinnamic acid derivatives usually found in mushrooms (Heleno et 
al., 2014). 
 
Phenolic acids are abundant in a balanced daily diet, showing different bioactivities such as 
antioxidant (Rice-Evans et al., 1996, Ferreira et al., 2009), antitumor (Carocho & Ferreira, 
2013), and antimicrobial (Alves et al., 2013a) properties. Cinnamic acid has strong capacity to 
inhibit the growth of human tumor cell lines such as non-small lung carcinoma (NCI-H460) 
(Vaz et al., 2012), colon carcinoma (HCT15) and cervical carcinoma (HeLa) cell lines 
(Heleno et al., 2014a, 2015). 
Mushrooms have been extensively studied due to their bioactive properties (Mau et al., 2002; 
Murcia et al., 2002; Yang et al., 2002; Ferreira et al., 2009) assigned to several molecules 
including phenolic acids (Valentão et al., 2005; Puttaraju et al., 2006; Ribeiro et al., 2007; 
Kim et al., 2008; Barros et al., 2009). Nevertheless, in vivo, these compounds are metabolized 
and circulate in the organism as glucuronated, sulphated and methylated metabolites (Heleno 
et al., 2014). 
Wild mushrooms and their mycelia as sources of bioactive compounds  
 
7 
Souilem Fedia 
The main phenolic acids reported in P. eryngii are p-hydroxybenzoic acid (3.81±0.41 mg/100 
g dw) (Reis et al., 2014), gallic acid and protocatechuic acid (Ferreira et al., 2009; Heleno et 
al., 2015). 
 
Figure 4.  General representation of the phenolic acids biosynthesis derived from the shikimic acid pathway. 
(Heleno et al., 2014). The numbers find the correspondence in the entries of Table 2. 
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Table 2. Main enzymes involved in the biosynthesis of phenolic acids through shikimate pathway from L- 
phenylalanine or L- tyrosine. 
Entry Starting molecule Enzyme Final compound 
 
1 
 
 
 
 
Phenylalanine  
 
Phenylalanine 
ammonialyase (PAL) 
 
 
 
 
Cinnamic acid 
2 
 
Cinnamic acid 
Oxidase (presumed b-
oxidation) 
 
Benzoic acid 
3 
Benzoic acid 
Benzoic acid 4-hydroxylase 
 
p-Hydroxybenzoic acid 
4 
   
  p-Hydroxybenzoic acid 
p-Hydroxybenzoic acid  3-
hydroxylase 
     
                     
Gentisic acid  
5 
Protocatechuic acid 
Protocatechuic acid 5-
hydroxylase 
  
 Gallic acid 
6 
Protocatechuic acid 
Protocatechuic acid 3-O-
methyltransferase 
   
Vanillic acid 
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7 
Vanillic acid 
Vanillic acid 4-O-
methyltransferase 
    
Veratric acid 
8 
 
Vanillic acid 
Vanillic acid 5 hydroxylase 
and vanillic acid 5-O-
methyltransferase 
  
Syringic acid 
9 
 
Cinnamic acid 
Cinnamic acid 4-
hydroxylase 
 
p-Coumaric acid 
10 
 
L- Tyrosine 
Tyrosine ammonia lyase 
(TAL) 
 
p-Coumaric acid 
11 
 
p-Coumaric acid 
p-Coumaric acid 3-
hydroxylase 
 
Caffeic acid 
12 
 
Caffeic acid 
Caffeic acid 3-O-
methyltransferase 
 
Ferulic acid 
13 
 
Ferulic acid 
Ferulic acid 5-hydroxylase 
and caffeic/5-hydroxyferulic 
acid O-methyltransferase 
(COMT) 
 
Sinapic acid 
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2.2  Ergosterol 
The presence of sterols in animals, plants and fungi has been reported by Barreira & Ferreira, 
(2015). They are organic compounds with a tetracyclic structure of four rings linked together, 
of three to six carbons and other ring with five carbons (steroid nucleus) (Figure 5) with a 
hydroxyl group at the C3 position and an aliphatic chain linked to the steroid nucleus (Fahy et 
al., 2005). 
 
Figure 5 . Steroid nucleus. 
Ergosterol is evidently the main sterol found in mushrooms, being a precursor of vitamin D2 
(Figure 6) (Mattila et al., 2002; Barreira & Ferreira, 2015). 
 
 
 
Figure 6. Chemical structure of ergosterol. 
14 
 
Caffeic + quinic acid 
4-Caffeate CoA ligase and 
quinate Ohydroxycinnamoyl 
transferase 
 
3,4 or 5-O-caffeoylquinic acid 
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Ergosterol is a solid compound, crystalline, colourless with the scientific name 5,7,22-
ergostatrien-3β-ol, the empirical formula C28H44O and a molecular weight of 396.36 g/mol. 
Its melting point is in the order of 161-166ºC. In addition, ergosterol supports the temperature 
of 250 °C without decomposition. It has a side chain with a double bond at C22 and two 
double bonds at the level of positions C5 and C7 (ring B), giving a maximum absorption in 
the UV in a range of 240 to 300 nm (Barreira et al., 2014). Ergosterol is practically insoluble 
in water; however, it is soluble in organic solvents, such as chloroform. Exposure to 
ultraviolet light causes a photochemical reaction that converts ergosterol to ergocalciferol 
(vitamin D2) (Villares et al., 2012). 
According to Barreira et al., (2014), ergosterol can be determined by different analytical 
methods such as high performance liquid chromatography coupled to ultraviolet detection. 
Savón et al., (2002) and Jasinghe & Perera, (2005) reported that the concentration of 
ergosterol in mushrooms, depends on the part of the mushroom tissue, developmental stage, 
growth conditions, and environmental factors. 
Sterols, in general, have been reported to play several biological functions that include 
antioxidant (Shao et al., 2010), anti-inflammatory (Kuo et al., 2011) and antitumoral activity 
(Villares et al., 2012; Barreira & Ferreira, 2015), having also the ability to activate the 
expression of specific defense genes (Lochman & Mikes, 2005). Furthermore, these 
compounds permit a reduction in pain related inflammation, reduce cardiovascular disease 
and inhibit cyclooxygenase (COX) enzymes (Yasukawa et al., 1994; Zhang et al., 2002; Ravi 
& Abplanalp, 2003). 
The ergosterol content in Pleurotus eryngii obtained after Soxhlet extraction with hexane and 
a saponification step was 187±1 mg/100 g dw (Barreira et al., 2014). 
3. Bioactivity of wild mushroom extracts  
Mushrooms grow in darkness and dampness in highly competitive environments and protect 
themselves from microbes by excretion of natural substances; this explains their richness in 
bioactive compounds (Ferreira et al., 2010). 
In fact, mushrooms have been considered to have excellent nutritional attributes (Kalac, 
2009). Their medicinal properties have been studied which include antioxidant (Puttaraju et 
al., 2006; Ferreira et al., 2009; Heleno et al., 2015), antitumor (Moradali et al., 2007; Ferreira 
et al., 2010; Carocho & Ferreira, 2013), antimicrobial (Alves et al., 2012, 2013), 
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immunomodulator (Borchers et al., 2008), antiatherogenic (Mori et al., 2008), hypoglycemic 
(Hu et al., 2006) and anti-inflammatory (Taofiq et al., 2016) activities.  
3.1  Antioxidant activity 
Oxidation is essential to many organisms, which can produce energy to fuel biological 
processes (Huanga et al., 2015).  
A free radical is an atom or molecule possessing unpaired electrons in the outer orbit, 
generally unstable and very reactive (Halliwell & Gutteridge, 1999; Gutteridge & Halliwell, 
2000; Carocho & Ferreira, 2013a). Free radicals and non-radical species are produced in the 
normal metabolism of aerobic cells, mostly in the form of oxygen or/and nitrogen reactive 
species (ROS or/and RNS) (Valko et al., 2007; Ferreira et al., 2009). They can be produced in 
the mitochondria, through xanthine oxidase, peroxisomes, inflammation processes, and 
phagocytosis, among other. Nevertheless, some external factors also help to promote the 
production of free radicals such as smoking, environmental pollutants, radiation, drugs, 
pesticides, industrial solvents and ozone (Figure 7) (Ferreira et al., 2009). 
 
 
 
 
 
 
 
 
   
 
Figure 7. Major causes for over production of free radical (oxidative stress), possible cellular targets and 
conditions that were associated to oxidative stress (Ferreira et al., 2009). 
Free radicals are neutralized by cellular antioxidant defenses such as enzymes and non-
enzymatic molecules. Maintaining the equilibrium between free radicals production and 
antioxidant defenses is an essential condition for normal organism functioning; this 
equilibrium might be displaced either by the overproduction of ROS or by the loss of the cell 
antioxidant defenses (Figure 8) (Ferreira et al., 2009; Lobo et al., 2010; Carocho & Ferreira, 
2013a). When free radicals are in excess, the organism is in oxidative stress, and this situation 
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Protein 
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leads to oxidation and damage of cellular lipids, proteins and DNA, and causing several 
diseases including cancer, cardiovascular diseases, neurological disorders, renal disorders, 
liver disorders, hypertension, among others (Valko et al., 2007; Ferreira et al., 2009; Lobo et 
al., 2010, Carocho & Ferreira, 2013a). Several ROS production pathways and the main 
endogenous antioxidant defenses of the cell are described in Figure 9 (Ferreira et al., 2009). 
Moreover, the synthetic antioxidants most commonly used in industrial processing may be 
cytotoxic. Thus, it is necessary to enhance natural and nontoxic antioxidants (Yating et al., 
2015), that can be found in mushrooms. 
 
Figure 8. Natural antioxidants separated in classes. Green words represent exogenous antioxidants, while yellow 
ones represent endogenous antioxidants (Carocho & Ferreira, 2013a). 
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Figure 9.  Overview of the main reactions involving reactive Oxygen species (ROS) / reactive Nitrogen species 
(RNS), and major endogenous enzymatic and non-enzymatic antioxidant defenses in the cell. The most 
representative endogenous sources (traced rectangles) of ROS/RNS are presented and include: Mitochondrial 
ETS (Electron transport system), NADPH oxidases, Xanthine oxidase for ROS and NO synthases for RNS. The 
main antioxidant defenses are presented in shaded rectangles and the enzymes involved are presented in italic. 
Molecular Oxygen (O2), superoxide anion(O2•), hydrogen peroxide (H2O2), hydroxyl radical (HO•), hydroxide 
ion (HO-), membrane lipids (LH), lipid radical (L•), peroxyl radical (LOO•), hydroperoxide lipid (LOOH), lipid 
alkoxyl radical (LO•), nitric oxide (NO•), radicals (R•), non-radicals (R), alcohols (LOH), glutathione (GSH), 
glutathione disulphide (GS-SG), α-tocopherol or vitamin E (vit. E), vitamin E radical (vit. E•), vitamin C (vit. C), 
vitamin C radical (vit. C•), S-nitrosoglutathione (GSNO), nicotinamide adenine dinucleotide phosphate: oxidized 
(NADP+), reduced (NADPH). Enzymes: superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase 
(GPx), glutathione redutase (Gred), glutathione- S-transferases (GST), Mitochondrial ETS (electron transport 
system), nitric oxide synthase (NOS) (Ferreira et al., 2009). 
In this context, mushrooms contain many different compounds with powerful antioxidant 
activities, such as phenolic compounds and vitamins (Ferreira et al., 2009) that help the 
organism in the combat against oxidative stress. As an example, Table 3 shows antioxidant 
effects in extracts prepared from the fruiting bodies of the species studied within the present 
work. 
Particularly, P. eyngii showed high reducing power and free radical-scavenging activity (Reis 
et al., 2014). 
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Table 3.  Antioxidant activity of methanolic extracts prepared from fruiting bodies and mycelia of the species 
studied within this work. 
DPPH: 2,2-Diphenyl-1-picrylhydrazyl; TBARS: thiobarbituric acid reactive substances; EC50: Extract 
concentration corresponding to 50% of antioxidant activity or 0.5 of absorbance for the Ferricyanide/Prussian 
blue assay. GAE:  Gallic acid equivalents. 
3.2   Anti-inflammatory activity 
Inflammation is a biological response to eliminate the initial cause of cell injury or harmful 
toxins stimuli such as pathogens, damaged cells, or irritation. However, inflammation may 
lead to many diseases including atherosclerosis, obesity, metabolic syndrome, diabetes and 
cancer (Moro et al., 2012; Taofiq et al., 2016). Macrophages are important components of the 
immune system, and they play a crucial role in the inflammatory response by supplying an 
immediate defense against foreign agents and release of excess pro-inflammatory mediators 
such as interleukins (IL-1β, IL-6, IL-8), tumor necrosis factor (TNF-α), nuclear factor-κB 
(NF-κB), intercellular adhesion molecule-1 (ICAM-1), inducible type cyclooxygenase-2 
(COX-2), prostaglandin E2 (PGE2), 5-lipoxygenase (5-LOX), and inducible nitric oxide 
synthase (iNOS) that leads to the production of reactive nitrogen species such as nitric oxide 
(NO). Overproduction of these inflammatory mediators leads to different kinds of cell damage 
(Joo et al., 2014; Taofiq et al., 2015). 
Therefore, pharmacologic treatment with anti-inflammatories generally begins with 
nonsteroidal anti-inflammatory drugs (NSAIDs). In contrast, the long-term administration of 
NSAIDs is associated with a poor safety profile on gastrointestinal, cardiovascular, renal, also 
high blood pressure and acute tubular necrosis (Taofiq et al., 2015; Rovati et al., 2016).  
Species Part Antioxidant assay 
Pleurotus eryngii 
(Reis et al., 2012) 
Fruiting body 
Mycelium (MMN) 
Folin Ciocalteu assay mg (GAE/g extract) 
                                                                                                                                                                                                                                         
7.14 ± 2.01  
9.11 ± 0.23 
Fruiting body 
Mycelium (MMN) 
Ferricyanide/Prussian blue assay; EC50 (mg/mL) 3.72 ± 0.09  
3.81 ± 0.02   
Fruiting body 
Mycelium (MMN) 
DPPH scavenging activity assay; EC50 (mg/mL)  
 
8.67 ± 0.12  
25.40 ± 0.33  
Fruiting body  
Mycelium (MMN) 
-carotene/linoleate assay; EC50 (mg/mL)  4.68 ± 0.60 
1.43 ± 0.60 
Fruiting body 
Mycelium (MMN) 
TBARS assay; EC50 (mg/mL) 3.95 ± 0.58 
21.03 ± 0.45 
Suillus bellinii 
(Ribeiro et al., 
2006) 
Fruiting body 
DPPH scavenging activity assay: At 150 
µg/mL, 35% of scavenging activity. 
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In this case, discovering of natural bioactive compounds with anti-inflammatory properties 
and without or lower toxic impact is essential. Mushrooms have also demonstrated some anti-
inflammatory potential based on their ability to reduce the production of inflammatory 
mediators (Taofiq et al., 2016). 
Previous research studies have been carried out on several mushroom species, mainly in 
methanolic and ethanolic extracts (Table 4). 
Table 4. Anti-inflammatory activity of extracts prepared from fruiting bodies of the species studied within this 
work. 
Species Extract NO production inhibition 
Pleurotus eryngii Ethanolic 
 
EC50 value: 388 ± 17 μg/mL (Taofiq et al., 2015). 
Suillus bellinii                     Not available in literature. 
EC50: Extract concentration corresponding to 50% of NO production inhibition. 
3.3  Cytotoxic activity 
Carcinogenesis is one of the most life-threatening diseases and causes severe health problems 
in both developed and developing countries. It is a process which normally takes several years 
during which progressive genetic changes occurs leading to malignant transformations 
(Ferreira et al., 2010; Jemal et al., 2011; Carocho & Ferreira, 2013; Rashed et al., 2014). 
Several endogenous causes are known to increase the risk of cancer. They include external 
factors such as smoking, dietary factors, infections, exposure to radiation, lack of physical 
activity, obesity, and environmental pollutants (Anand et al., 2008), and internal factors such 
as chromosomal abnormalities, somatic mutations, and immunological surveillance (Carocho 
& Ferreira, 2013a). 
Furthermore, literature suggests that there is a link between cancer and oxidative stress. 
Therefore, the consumption of foods with antioxidant activity may reduce oxidative stress 
associated to these diseases (Vaz et al., 2010). 
To prevent the growing understanding of the molecular biology of cancer, chemotherapy is 
used as therapeutic modalities for the treatment of cancer, but most of the anticancer drugs 
applied in chemotherapy are cytotoxic to normal cells. Consequently, searching for natural 
anticancer drugs with low toxicity and high efficacy becomes very important (Ren et al., 
2016). 
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In this context, mushrooms are a vast source of powerful potential pharmaceutical drugs. 
They have been established to inhibit the growth of different tumor cell lines (Poucheret et al., 
2006). Moreover, both cellular components and secondary metabolites of a large number of 
mushrooms have anticarcinogenic actions including, low-molecular-weight (LMW), and 
high-molecular-weight compounds (HMW) (Figure 10) (Wasser & Weis, 1999; Ferreira et 
al., 2010). 
Mushrooms have powerful capacities against cancers of the stomach, esophagus, and lungs, 
among others and are known in China, Japan, Korea, Russia, United States and Canada 
(Ferreira et al., 2010).  
The most important molecules found in mushrooms with antitumor potential are 
polysaccharides and phenolic compounds or derivatives (Vaz et al., 2012). 
Several recent studies have indicated that P. eryngii polysaccharides can inhibit the growth of 
several types of cancer (Ren et al., 2016) (Table 5). 
 
Figure 10. Low-molecular-weight (LMW) and high-molecular-weight (HMW) compounds with antitumor 
potential found in mushrooms (Ferreira et al., 2010). 
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Table 5.  Cytotoxic activity of extracts prepared from fruiting bodies of the species studied within this work. 
Species Extract Type of activity 
Pleurotus eryngii Polysaccharidic 
 
Inhibited HepG-2 proliferation, induced apoptosis, cell cycle arrest at 
the S-phase and intracellular ROS production (Ren et al., 2016). 
Suillus bellinii                         Not available in literature. 
4. Production of mushroom mycelia by in vitro culture 
4.1  In vitro culture applied to mushrooms 
The filamentous fungi are characterized by being non-mobile organisms composed of an 
organized mass of threadlike cells called hyphae (the assembly of hyphae are called 
mycelium), having a life cycle with sexual and asexual reproduction that results in spores 
production, usually from a common haploid "stem" resulting from zygotic meiosis and 
heterotrophic nutrition (Griffin, 1994; Alexopoulos et al., 1996). 
Leiva et al., (2015) pointed out that mycelium growth is affected by the in vitro conditions, 
such as size of the inoculum, the period of incubation, pH, temperature, composition of 
media, thus, cultures on agar and in liquid media are excellent models and are responsible for 
mycelium development. PDA (Potato Dextrose Agar) and MMN (Melin-Norkrans medium) 
have been the successfully media for the cultivation of many wild mushrooms as 
demonstrated by Pinto et al., (2013). 
Stamets and Chilton, (1983) explain the methodology of culture in solid medium: “Cut a piece 
of the interior cap tissue or the upper region of the "stem" from mushroom and put the 
fragment at the center of a Petri dish. This technique takes place in a sterile area to avoid 
contamination (yeast, bacteria), that would stop the growth of mycelia”. 
In vitro culture methodology (for mycelia production) is used as alternative products of 
fruiting bodies, containing numerous advantages including the shorter cultivation time, 
storage of mycelia for a long period without genetic alterations, contamination can be easily 
observed and monitored on the flat of media, so it is easy to know and retain pure culture, it is 
also important for the preservation of endangered or rare species (Stamets & Chilton, 1983; 
Ferreira et al., 2009; Zilly et al., 2011; Heleno et al., 2012; Pinto et al., 2013). In addition to 
these advantages, in vitro culture allows the scaling up of biomass production for 
biotechnological purposes. Not only fruiting bodies, but also mycelia are a source of 
nutraceuticals and functional foods.  Extraction and purification of bioactive compounds such 
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as polysaccharides (Chen et al., 2013), phenolic compounds (Reis et al., 2012) and some other 
from mycelium it’s easy, and could be isolated for medicinal purposes (Pinto et al., 2013), 
including antioxidant, anti-inflammatory, antitumor, antimicrobial, antiviral, antidiabetic, 
immunomodulatory, cardiovascular, liver protective, and antifibrotic properties (Borchers et 
al., 2004; Gonçalves et al., 2011). In this context, Reis et al., (2012) was the first publication 
comparing in vivo and in vitro culture in terms of bioactivity. 
Different media influence growth rates and mycelia biomass production, since liquid MMN 
media contains available nutrients and oxygen leading to higher mycelia absorption of 
nutrients, thus a faster growth and higher mycelia biomass (Heleno et al., 2012). On other 
hand, culture media also may influence the bioactivity of mycelium. Heleno et al., (2012) 
demonstrated that PDA is the most indicated medium to increase the antioxidant activity of G. 
lucidum mycelium. 
Corrêa et al., (2016) in a recent review reported that Pleurotus spp mycelium has high 
nutritional profile that determines a precious aroma, characteristic flavor, and 
pharmacological value being a source of important bioactive compounds such as peptides, 
glycoproteins, polysaccharides, lipids and hydrolytic and oxidative enzymes with antioxidant, 
antimicrobial, anti-inflammatory, antitumor and immunomodulatory effects. 
4.2   Case-studies with wild mushrooms  
The antioxidant properties of wild mushrooms with their content in antioxidant compounds 
including tocopherols, can detoxify damaging forms of activated oxygen. A comparative 
study of tocopherols composition and antioxidant properties of in vivo (fruiting bodies) and in 
vitro (mycelia) ectomycorrhizal fungi: Paxillus involutus and Pisolithus arhizus was carried 
out by Reis et al., (2011). Mycelia showed higher levels of total tocopherols than fruiting 
bodies, and particularly P. arhizus mycelium demonstrated to be an efficient source of -
tocopherol. 
A systematic study was performed in order to compare the antioxidant activity of phenolic 
and polysaccharidic extracts from fruiting body, spores and mycelium, obtained in three 
different culture media, of Ganoderma lucidum. The highest levels of total polysaccharides 
(~14 mg/g extract) and individual sugars were detected in mycelia collected from solid culture 
media (Heleno et al., 2012). 
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Another study examines a comparison of the antioxidant activities and phenolic profile of 
cultivated mushrooms and their mycelia: Agaricus bisporus, Pleurotus ostreatus, Pleurotus 
eryngii and Lentinula edodes. L. edodes mycelia have the highest reducing power. Generally, 
in vivo samples detected higher antioxidant activities than their mycelia obtained by in vitro 
culture. On the other hand, phenolic compounds were revealed both in mushrooms and 
mycelia without any particular abundance. Results demonstrated that there is no correlation 
between mushrooms and their mycelia obtained in vitro, thus in vitro production may be used 
as a source of bioactive compounds (Reis et al., 2012). 
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5. Objectives 
The main goals of the present work were to produce, chemically characterize and evaluate the 
bioactivity of mycelia of two mushrooms  species, Pleurotus eryngii and Suillus bellinii, 
obtained by in vitro culture, using different solid and liquid culture media: iMMN (incomplete 
Melin-Norkans medium) and PDA/PDB (Potato Dextrose Agar/ Potato Dextrose broth 
media). 
Furthermore, the mycelia produced, their fruiting body and the culture media were: 
i) Chemically characterized in terms of phenolic acids and ergosterol by HPLC-DAD 
and HPLC-UV, respectively; 
ii)  Evaluated regarding antioxidant (free radicals scavenging activity, reducing 
power and lipid peroxidation inhibition), anti-inflammatory (NO production 
inhibition in mice macrophages) and cytotoxic (in human tumor cell lines and in a 
non-tumor porcine primary liver cell culture) properties. 
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CHAPTER 3. MATERIALS AND METHODS  
1. Wild samples and in vitro production of mycelia 
Two species of wild mushrooms (Pleurotus eryngii (DC.) Quél. and Suillus bellinii (Inzenga) 
Watling) were collected in Bragança (Northeast Portugal) during November 2015. Mycelium 
was isolated from sporocarps of each sample on different solid: i) potato dextrose agar 
medium (PDA) (Biolab); ii) Melin-Norkans incomplete medium (without micronutrients, 
casaminoacids and malt extract) (iMMN solid), and liquid: i) potato dextrose broth (PDB); ii) 
Melin-Norkans incomplete (without micronutrients, casaminoacids and malt extract) (iMMN 
liquid) culture media (Marx, 1969).  
Mycelia were grown in Petri dishes with 10 mL of solid media and flasks with 20 mL of 
liquid media. Petri dishes and flasks were placed at 22 °C in the dark until mycelium covered 
most of the medium: 21 days for P. eryngii and 42 days for S. bellinii, approximately. Radial 
growth measurements were registered every week from the inoculation time until the full 
growth of the mycelium (covering all available area). The mycelia were further recovered 
from the medium. 
Fruiting bodies, mycelia and culture media were lyophilized (FreeZone 4.5, Labconco, MO, 
USA), ground to a fine powder (20 mesh) and weighted to obtain the dry biomass (dw). 
2. Standards and reagents  
The solvents acetonitrile 99.9% and methanol were of high-performance liquid 
chromatography (HPLC) grade from Lab-Scan (Lisbon, Portugal). Ergosterol, phenolic 
compounds (gallic, protocatechuic; p-hydroxybenzoic, p-coumaric, and cinnamic acids) and 
trolox (6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid) standards were purchased 
from Sigma (St. Louis, MO, USA). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained 
from Alfa Aesar (Ward Hill, MA, USA). Dulbecco’s modified Eagle’s medium, hank’s 
balanced salt solution (HBSS), fetal bovine serum (FBS), L-glutamine, trypsin-EDTA, 
penicillin/streptomycin solution (100 U/mL and 100 mg/ mL, respectively) were purchased 
from Gibco Invitrogen Life Technologies (Paisley, UK). Sulforhodamine B, trypan blue, 
trichloroacetic acid (TCA) and Tris were purchased from Sigma Chemical Co. (Saint Louis, 
MO, USA). RAW264.7 cells were purchased from ECACC (“European Collection of Animal 
Cell Culture”) (Salisburg, UK), lipopolysaccharide (LPS) from Sigma and DMEM medium 
from HyClone. The Griess Reagent System Kit was purchased from Promega, and 
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dexamethasone from Sigma. Thiamine, casamino acids, malt extract and agar were obtained 
from Panreac AppliChem (Barcelona, Spain). PDA and PDB were acquired from Oxoid 
microbiology products (Hampshire, United Kingdom). All other reagents and solvents were of 
analytical grade and obtained from common sources. Water was treated in a Milli-Q water 
purification system (TGI Pure Water Systems, Greenville, SC, USA). 
3. Preparation of the extracts 
The extraction was carried out by stirring the samples (≈2 g) with methanol (30 mL) at 25°C 
and 150 rpm, for 1 h. The extract was separated from the residue by filtration through 
Whatman No. 4 paper to a round flask. The residue was re-extracted once more and the 
filtrates were combined and concentrated under vacuum (rotary evaporator, Büchi, Flawil 
Switzerland) (figure 11) (Reis et al., 2012). 
 
 
 
 
 
Figure 11. Step of solvent removal in the preparation of the extracts. 
4. Chemical characterization of the extracts 
4.1 Analysis of phenolic acids 
The final extracts were dissolved in methanol:water 20:80 (v/v) at 20 mg/mL and filtered 
through a 0.22 μm nylon disposable filter. The analysis was performed using a Shimadzu 20A 
series ultra-fast liquid chromatograph (UFLC, Shimadzu Coperation, Kyoto, Japan) as 
previously described by  Reis et al., (2012) (figure 12). Separation was achieved on a Waters 
Spherisorb S3 ODS2 C18 column (3 µm, 150 mm x 4.6 mm) thermostatted at 35ºC. The 
solvents used were: (A) 0.1% formic acid in water, (B) acetonitrile. The elution gradient 
established was 10% B to 15% B over 5 min, 15–25% B over 5 min, 25–35% B over 10 min, 
isocratic 50% B for 10 min, and re-equilibration of the column, using a flow rate of 0.5 
mL/min. Detection was carried out in a photodiode array detector (PDA), using 280 nm as the 
preferred wavelength. 
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The phenolic acids were quantified by comparison of the area of their peaks recorded at 280 
nm with calibration curves (5-100 µg/mL) obtained from commercial standards of each 
compound:  
Protocatechuic acid (y = 164741x, R2=0.9996), p-hydroxybenzoic acid (y = 113523x, 
R2=0.9993), p-coumaric acid (y = 433521x, R2=0.9981) and cinnamic acid (y = 583527x, 
R2=0.9961). The results were expressed as µg per g of extract.  
 
 
 
 
 
 
 
Figure 12.  HPLC-DAD equipment used in the analysis of phenolic acids. 
4.2 Analysis of ergosterol  
The final extracts were dissolved in methanol at 20 mg/mL and filtered through a 0.22 μm 
nylon disposable filter. Ergosterol analysis was performed by high performance liquid 
chromatography coupled to an ultraviolet detector (HPLC-UV) as previously described by 
Barreira et al., (2014) (Figure 13). The components of the HPLC-UV integrated system 
include a pump (Knauer, Smartline system1000, Berlin, Germany), an UV detector (Knauer 
Smartline 2500), a degasser system (Smartline manager 5000) and an injector (autosampler) 
(AS-2057 Jasco, Easton, MD, USA). Chromatographic separation was performed with an 
Inertsil 100A ODS-3 reversed-phase column (4.6×150 mm, 5 μm BGB Analytik AG, 
Boeckten, Switzerland) at 35 °C (7971R Grace oven). The mobile phase was 
acetonitrile/methanol (70:30, v/v), at a flow rate of 1 mL/min, and the injection volume was 
20 μL. The detection was performed at 285 nm and data were analysed using Clarity 2.4 
Software (DataApex). Ergosterol was quantified by comparing the area of its peak with the 
calibration curve obtained from a commercial standard. Quantification was performed using 
the internal standard method and cholecalciferol was used as internal standard. The results 
were expressed in mg per g of extract. 
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Figure 13.  HPLC-UV system used in the analysis of ergosterol. 
5. Evaluation of bioactive properties  
5.1 Antioxidant activity 
The final extracts were dissolved in methanol at appropriate concentrations (10-80 mg/mL) 
and several dilutions were obtained from the stock solutions: 0.005-50 mg/mL, depending on 
the assay. 
The in vitro antioxidant activity of the extracts was evaluated by four different assays: DPPH 
radical-scavenging activity, reducing power, β-carotene bleaching inhibition and 
thiobarbituric acid reactive substances (TBARS) assay (Heleno et al., 2010). Trolox was used 
as positive control. 
5.1.1 DPPH radical scavenging activity 
In this assay, the deep violet chromogen DPPH radical is reduced to slight yellow color in the 
presence of hydrogen donating antioxidants leading to the formation of non-radical form. The 
reaction mixture consisted of one of the different concentrations of the diluted methanolic 
extracts (30 μL) and methanolic solution (270 μL) containing DPPH radicals (6×10-5 mol/L). 
The microplate was stored in the dark at 25 ºC for 1h. Absorbances were recorded using 
ELX800 microplate Reader (Bio-Tek Instruments, Inc.; Winooski, VT, USA) at 515 nm 
(Figure 14). 
The results were expressed in mg/mL as the extract concentration responsible for 50% of 
DPPH radical scavenging activity (EC50), calculated by interpolation from the graph of the 
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radical scavenging activity (RSA) percentage against extract concentration and expressed in 
mg/mL of extract.  
%RSA = [(ADPPH-AS)/ADPPH] ×100, (AS- absorbance of the solution when the sample extract 
has been added at a particular level and ADPPH- absorbance of the DPPH solution). 
 
 
 
 
 
 
 
Figure 14.  Microplate used in the evaluation of DPPH radical-scavenging activity. 
5.1.2 Reducing power 
This methodology is based on the ability to reduce yellow ferric form (Fe3+) to blue ferrous 
form (Fe2+) by the action of electron-donating antioxidants (Benzie et al., 1999). 
Different concentrations of the methanolic extracts (0.5 mL), sodium phosphate buffer (0.5 
mL, 200 mmol/L, pH 6.6) and potassium ferricyanide (0.5 mL, 1% w/v) were mixed in 
eppendorf tubes. The tubes were incubated at room temperature (50 °C) for 20 min. After the 
addition of trichloroacetic acid (0.5 mL, 10% w/v), the mixture (0.8 mL) was transferred into 
48 well microplates as also deionized water (0.8 mL) and ferric chloride (0.16 mL, 0.1% w/v). 
Absorbance was then read at 690 nm in the microplate reader mentioned above (Figure 15). 
The extract concentration providing 0.5 of absorbance (EC50) was calculated from the graph 
of absorbance against extract concentration and expressed in mg/mL of extract.  
.  
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Figure 15.  Microplate used in the evaluation of reducing power. 
5.1.3 Inhibition of 𝛽-carotene bleaching  
This assay is based on the capacity of antioxidants to neutralize the linoleate free radical. This 
neutralization is detected by the discoloration of the yellowish color of 𝛽-carotene. 
The reagent is prepared by dissolving 2 mg of 𝛽-carotene in 10 mL of chloroform in a round-
bottom flask. This solution was concentrated in a rotary evaporator to remove the chloroform, 
and then 400 mg of Tween 80 emulsifier, 2 drops of linoleic acid and 100 mL of distilled 
water were added to the flask with vigorous agitation. About 4.8 mL of this mixture were 
added to 0.2 mL of each dilution distributed in test tubes. After reading zero time absorbance 
at 470 nm, the tubes were incubated in a water bath at 50 °C with agitation (100 rpm) for 2h, 
and the absorbances were measured for the second time at 470 nm (UV–Vis 
spectrophotometer SPECORD 200, Analytik Jena AG, Jena, Germany) (Figure 16). 𝛽-
carotene bleaching inhibition was calculated through this equation: (absorbance after 2 h of 
assay/initial absorbance) × 100 and further converted to EC50 (extract concentration 
responsible for 50% of 𝛽-carotene bleaching inhibition), expressed in mg/mL of extract. 
 
 
 
 
 
 
Figure 16.  Test tubes used in the β-carotene/linoleate assay. 
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5.1.4 Thiobarbituric acid reactive substances (TBARS) assay  
TBARS is a colorimetric assay in which lipid peroxidation produces malondialdehyde (MDA) 
as secondary breakdown product, and reacts with the thiobarbituric acid (TBA) to form 
MDA-TBA complex with the production of a pink pigment (Ndhlala et al., 2010). 
The inhibition of lipid peroxidation in porcine (Sus scrofa) brain homogenates in the presence 
of antioxidant is detected by measuring the absorbance of MDA-TBA complex at 532 nm. 
Porcine brains were purchased from a local slaughter house, dissected and dissolved in Tris-
HCl buffer (20 mmol/L, pH 7.4) in a proportion of 1:2 w/v brain tissue homogenate which 
was centrifuged at 3000 g for 10 min. Each dilution of the sample solutions (200 μL) was 
pipetted into test tubes, adding also 100 μL of ascorbic acid (0.1 mmol/L), 100 μL of FeSO4  
(10 mmol/L) and 100 μL of the supernatant of brain tissue homogenate. The tubes were 
incubated at 37 °C for 1h. Trichloroacetic acid (500 μL, 28% w/v) was added to stop reaction, 
together with 380 μL thiobarbituric acid (TBA, 2% w/v), and the mixture was then incubated 
at 80 °C for 20 min. The mixtures were centrifuged at 3500 rpm for 5 min to eliminate the 
precipitated protein; the absorbances of the supernant samples were measured at 532 nm 
(Figure 17). The percentage of inhibition was calculated through this equation: inhibition 
ratio (%) = [(A−B)/A] × 100; (A- absorbance of the control and B- absorbance of the sample 
solution) and converted to EC50 values (extract concentration responsible for 50% of lipid 
peroxidation inhibition) expressed in mg/mL of extract.  
 
 
 
 
 
 
 
 
Figure 17. Test tubes used in the TBARS assay. 
5.2 Anti-inflammatory activity 
The final extracts were dissolved in water at 8 mg/mL and several dilutions were obtained 
from the stock solutions 0.005 to 0.4 mg/mL.  
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5.2.1 Cells treatment  
The mouse macrophage-like cell line RAW264.7 was cultured in DMEM medium 
supplemented with 10% heat-inactivated foetal bovine serum, 100 U/mL penicillin and 100 
mg/mL streptomycin and were incubated at 37 ºC in a humidified atmosphere containing 5% 
CO2. For each experiment, cells were detached with a cell scraper. Under our experiment cell 
density (5 x 105 cells/mL), the proportion of dead cells was less than 1%, according to Trypan 
blue dye exclusion tests. 
Cells were seeded in 96-well plates at 150.000 cells/well and allowed to attach to the plate 
overnight. Then, cells were treated with the different concentrations of each of the extracts for 
1h. Dexamethasone (50 µM) was used as a positive control for the experiment. The following 
step was stimulation with LPS (1 µg/mL) for 18h. The effect of all the tested samples in the 
absence of LPS was also evaluated, in order to observe if they induced changes in NO basal 
levels. In negative controls, no LPS was added. Both extracts and LPS were dissolved in 
supplemented DMEM. 
5.2.2 Nitric oxide determination 
For the determination of nitric oxide, Griess Reagent System kit (Promega) was used, which 
contains sulfanilamide, N-(1-napthyl) ethylenediamine hydrochloride (NED) and nitrite 
solutions. A reference curve of the nitrite (sodium nitrite 100 µM to 1.6 µM; 
y=0.0064x+0.1311, R2=0.9981) was prepared in a 96-well plate. One hundred microliters of 
the cell culture supernatant was transferred to the plate in duplicate and mixed with 
sulfanilamide and NED solutions, 5-10 minutes each, at room temperature.  
The nitric oxide produced was determined by measuring the absorbance at 540 nm using 
microplate reader described above (Figure 18), and by comparison with the standard 
calibration curve. The percentage of inhibition of the NO production was calculated, for each 
sample concentration, by the equation: [(Substrate concentration - Basal cells)/LPS - Basal 
cells] x100. 
For an easier comparison of the results, EC50 values were calculated based on 50% of 
inhibition of NO production (expressed in μg/mL extract). 
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Figure 18.  Microplate showing the NO assay with methanolic extracts. 
5.3 Cytotoxic activity 
The final extracts were dissolved in water at 8 mg/mL and several dilutions were obtained 
from the stock solutions: 0.125 to 0.4 mg/mL. Ellipticine was used as positive control. 
5.3.1 In human tumor cell lines 
Four human tumor cell lines were used: MCF-7 (breast adenocarcinoma), NCI-H460 (non-
small cell lung carcinoma), HeLa (cervical carcinoma) and HepG2 (hepatocellular 
carcinoma).  
The cell lines were maintained with RPMI-1640 medium supplemented with 10% heat-
inactivated fetal bovine serum (FBS), glutamine (1%, 2 mM) and antibiotic (1%) at 37 ºC, in 
a humidified air incubator containing 5% CO2 for 24h. The medium was changed every 2 
days. The cell concentrations were determined by counting in a hematocytometer chamber 
under a microscope using trypan blue solution. 
For the determination of cell density, sulforhodamine B assay was used (Guimaraes et al., 
2013). In brief, the cell lines were cultured at an appropriate density (1×104 cells/mL per well 
in 96-well plates) and then treated with the different extract solution at 37°C in a humidified 
incubator with 5% CO2 for 48h. After incubation, cells were fixed with 100 𝜇l of 10% cold 
trichloroacetic acid (TCA) and maintained at 4∘C for 1h.  The plates were then washed with 
slow-running tap water and dried. Sulforhodamine B solution (0.1% in 1% acetic acid, 100 
𝜇L) was added to each plate well and left for 30 min at room temperature, and then quickly 
rinsed the plates with 1% acetic acid to remove unbound dye. The protein-bound dye was 
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solubilized in 200 𝜇l of 10 mM Tris base solution for the absorbance determination at 540 nm 
using the microplate reader mentioned above (Figure 19). 
 
 
 
 
 
 
Figure 19.  Microplate used in the evaluation of the methanolic extracts cytotoxicity. 
The extract concentration that inhibited 50% of the net cell growth (GI50) was calculated from 
the graph of sample concentration against percentage of growth inhibition and expressed in 
μg/mL extract. 
5.3.2 In non-tumor cells 
The effect of the extracts on the growth of porcine liver primary cells (PLP2), established by 
the group, was evaluated by the sulforhodamine B colorimetric assay with some modifications 
as described by Abreu et al., (2011). Brieﬂy, the liver tissues were rinsed in Hank’s balanced 
salt solution containing 100 U/mL penicillin and 100 µg/mL streptomycin and divided into 
1×1 mm3 explants. Some of these explants were placed in 25 cm3 tissue ﬂasks in DMEM 
supplemented with 10% fetal bovine serum, 2 mM nonessential amino acids and 100 U/mL 
penicillin, 100 mg/mL streptomycin and incubated at 37 ºC with a humidiﬁed atmosphere 
containing 5% CO2. The medium was changed every 2 days. Cultivation of the cells was 
continued with direct monitoring every 2-3 days using a phase contrast microscope. Before 
conﬂuence, cells were sub-cultured and plated in 96-well plates at a density of 1.0×104 
cells/well, and cultivated in DMEM medium with 10% FBS, 100 U/mL penicillin and 100 
µg/mL streptomycin. Cells were treated for 48 h with the different diluted sample solutions 
and the SRB assay was performed. The results were expressed in GI50 values (sample 
concentration that inhibited 50% of the net cell growth) in μg/mL extract. 
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6. Statistical  
For each culture component, fruiting body and fungal species, three independent samples 
were analysed. Data were expressed as mean ± standard deviation. All statistical tests were 
performed at a 5% significance level using IBM SPSS Statistics for Windows, version 22.0. 
(IBM Corp., USA). 
The fulfilment of the one-way ANOVA requirements, specifically the normal distribution of 
the residuals (data not shown) and the homogeneity of variance, was tested by means of the 
Shapiro Wilk’s and the Levene’s tests, respectively. All dependent variables were compared 
using Tukey’s honestly significant difference (HSD) or Tamhane’s T2 multiple comparison 
tests, when homoscedasticity was verified or not, respectively. 
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CHAPTER 4. RESULTS AND DISCUSSION 
1. Mycelia growth 
Edible mushrooms, in general, are esteemed primarily for their nutritional value and bioactive 
properties mostly provided by different active substances, such as polysaccharides, lipids, 
peptides, sterols, or fiber (Ren et al., 2016). The great majority of the studies reporting the 
previous features are conducted on the fruiting body, but the mycelia, as well as the culture 
media utilized in different stages of mushroom production, might also represent a good source 
of valuable compounds. 
Besides the differences in bioactive compounds and corresponding activities, each strain of 
mushroom produces a special type of mycelium and this range of characteristics varies in 
form, color and growth rate. P. eryngii presented depigmented and cottony mycelia, whereas 
S. bellinii had pigmented and rhizomorphic mycelia (Figure 20). 
 
 
 
 
 
 
Figure 20.  Pleurotus eryngii (a) and Suillus bellinii (b) mycelia cultivated in vitro, in both liquid (PDB and 
iMMN) and solid medium (PDA and iMMN). 
The growth rate and yielded biomass of mycelia are of paramount importance, since these 
parameters might define the industrial interest of each species. Accordingly, both indicators 
are presented in Figures 21, 22 and 23, to allow a proper assessment of their true 
applicability. P. eryngii and S. bellinii mycelia started to grow after 3 days of culture. For P. 
eryngii, the mycelium grown in PDA media showed the fastest radial growth and for S. 
bellinii, the mycelium grown in iMMN solid media showed the fastest radial growth. These 
results are in agreement with the already known better growth of mycorrhizal fungi in MMN 
medium when compared with PDA medium (Marx, 1969). The opposite is true for 
nonmycorrhizal species like P.eryngii. 
a b 
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Overall, P. eryngii presented a higher growth rate, despite the similarities in the produced 
biomass (except for the mycelia grown in PDB). This result is also in agreement with the 
known better in vitro growth of nonmycorrhizal fungi when compared to mycorrhizal. 
Symbiotic fungi are often very dependent on the host for survival and growth and require 
richer growth media. This was the reason for the development of MMN medium by Marx, 
(1969). Similarities in biomass production make the applicability of S. bellinii particularly 
interesting in case of positive bioactivity results for these mycelia. 
 
Figure 21. Growth in diameter of the mycelia of P. eryngii cultivated in different culture media throughout time. 
 
Figure 22. Growth in diameter of the mycelia of S. bellinii cultivated in different culture media throughout time. 
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Figure 23. Average biomass of P. eryngii and S. bellinii mycelia (mg/Petri dish or Flask). 
In the following sections, the mycelia and culture media are compared by evaluating different 
bioactive compounds and bioactivity indicators. In all tables, results corresponding to wild 
samples of each studied species are also presented as reference values.  
2. Chemical characterization of the extracts 
The phenolic acids profile and ergosterol contents are presented in Table 6. In general, the 
fruiting body presented higher contents in phenolic acids, but it was very interesting to find 
that the mycelium of S. bellinii (independently of the culture conditions) gave higher contents 
(8.9-12.4 mg/g extract) in ergosterol than the corresponding wild samples (6.5 mg/g extract). 
There are limited data on the sterols content of S. bellinii, but it was reported as having 12 
mg/100 g fw ergosterol (Kalogeropoulos et al., 2013), which is higher than the values 
reported in the present work.  
P. eryngii gave lower contents in ergosterol, either considering the mycelia (0.10-1.0 mg/g 
extract), as well as the fruiting body (4.1 mg/g extract), when compared to S. bellinii. The 
ergosterol content in P. eryngii fruiting body was previously reported as 20 mg/100 g dw 
(Barreira et al., 2014), but that higher value was measured in commercial samples, which 
might justify the difference in comparison to the result reported here. 
Among the phenolic acids, p-hydroxybenzoic acid was the major compound in both 
mushrooms, reaching quantities nearly sevenfold higher in S. bellinii fruiting body (1821 μg/g 
extract). Nevertheless, the main phenolic acid in S. bellinii was previously reported as being 
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p-hydroxyphenylacetic acid (45 μg/100 g fresh weight), among p-hydroxybenzoic acid 
derivatives, and o-coumaric acid (15 μg/100 g fresh weight), in what concerns 
hydroxycinnamic acids. In the same study, the concentration of p-hydroxybenzoic was 7 
μg/100 g fresh weight (Kalogeropoulos et al., 2013), which is in the range of the 
concentrations detected herein, considering typical moisture contents (≈90%) and extraction 
yields (≈5%) for this particular mushroom species.  
Concerning P. eryngii, the phenolic acids profile is in agreement with previous works 
conducted with samples from the same geographic area, but different harvesting years 
(Ferreira et al., 2009; Heleno et al., 2015; Reis et al., 2014). Even so, in a similar study, 
syringic acid and vanillic acid were reported in quantities similar to p-hydroxybenzoic acid 
(Lin et al., 2014). 
Table 6. Ergosterol content (mg/g extract) and phenolic acids composition (μg/g extract) in the mycelia and 
culture media of P. eryngii and S. bellinii. The values corresponding to the fruiting body of both mushrooms 
(wild samples) are also presented. Values are given as mean±standard deviation. 
 
Ergosterol 
Protocatechuic 
acid 
p-Hydroxybenzoic 
acid 
p-Coumaric 
acid 
Cinnamic 
acid 
Pleurotus eryngii 
Fruiting body (wild) 4.1±0.3 nd 273±10 42±4 61±4 
iMMN liquid 
Mycelium 0.6±0.1b nd 186±8a nd 34±3b 
Culture medium nd nd nd nd nd 
PDB 
Mycelium 0.10±0.02c nd 122±6c nd 49±4a 
Culture medium nd nd nd nd nd 
iMMN solid Mycelium 0.9±0.1a nd 149±9b nd 15±2c 
PDA Mycelium 1.0±0.1a nd 178±8a nd 15±2c 
p-values (n 
= 54) 
Homoscedasticity1 <0.001 - <0.001 - <0.001 
1-way ANOVA2 <0.001 - <0.001 - <0.001 
 
Suillus bellinii 
Fruiting body (wild) 6.5±0.4 403±16 1821±97 nd 39±4 
iMMN 
liquid 
Mycelium 8.9±0.5b nd 213±7c nd 130±1a 
Culture medium nd nd nd nd nd 
PDB 
Mycelium 12.4±0.5a nd 204±11c nd 111±4b 
Culture medium nd nd nd nd nd 
iMMN solid  Mycelium 9.0±0.4b nd 394±15a nd 25±2d 
PDA Mycelium 3.5±0.3c nd 372±16b nd 36±3c 
p-value (n = 
54) 
Homoscedasticity1 <0.001 - <0.001 - <0.001 
1-way ANOVA2 <0.001 - <0.001 - <0.001 
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nd- not detected. 1Homoscedasticity among culture components was tested by the Levene test: homoscedasticity, 
p>0.05; heteroscedasticity, p<0.05. 2p<0.05 indicates that the mean value of at least one component differs from 
the others (in this case, multiple comparison tests were performed). For each culture component, means within a 
column with different letters differ significantly (p<0.05). 
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3.  Antioxidant activity 
The results obtained for each of the performed antioxidant activity assays, given as EC50 
values, are shown in Table 7. In all evaluated cases, the highest activity was obtained on the 
TBARS formation inhibition assay (P. eryngii: 0.11 mg/mL extract; S. bellinii: 0.011 mg/mL 
extract), followed by β-carotene bleaching inhibition (P. eryngii: 0.45 mg/mL extract; S. 
bellinii: 0.12 mg/mL extract), reducing power (P. eryngii: 0.98 mg/mL extract; S. bellinii: 
0.16 mg/mL extract) and scavenging effects on DPPH radicals (P. eryngii: 12.8 mg/mL 
extract; S. bellinii: 0.61 mg/mL extract). In line with its higher quantities of phenolic acids, 
the fruiting bodies of S. bellinii showed higher antioxidant activity than P. eryngii, sometimes 
10-fold or 20-fold higher, such as verified in the TBARS formation inhibition and DPPH 
scavenging activity, respectively. In general, the values obtained for P. eryngii represent 
higher antioxidant activity (except for the DPPH scavenging activity assay) than that reported 
previously (Reis et al., 2012; Lin et al., 2014).  
In this context, phenolic acids are described as being important compounds with antioxidant 
activity in mushrooms due to the presence of OH groups in their chemical structures that are 
known for their ability to scavenge free radicals (Heleno et al., 2012a). 
Regarding S. bellinii, an activity of 35% in DPPH scavenging activity, at 0.15 mg/mL was 
previously reported (Ribeiro et al., 2006), which is slightly better than the 50% activity 
obtained in this study for the 0.61 mg/mL concentration. In a similar study, performed with 
Greek samples of S. bellinii, this mushroom also showed high radical scavenging activity and 
reducing power, but the results are not directly comparable, because they were given in trolox 
equivalents (Kalogeropoulos et al., 2013). 
Considering the main purpose of this work, it was very interesting to discover that the 
antioxidant activity measured in the mycelia and in the culture media was very close (in some 
cases better) to that verified in the fruiting bodies, emphasizing the high potential of these 
fungal culture components. In the case of the culture media, these results have an increased 
interest, since those components are usually considered as by-products of mushroom 
cultivation. Furthermore, the differences among the same culture media, after having been 
used to grow each of the mushrooms, indicate that the measured antioxidant activity is in fact 
due to the mycelium, and not to the culture media components. Furthermore, some 
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compounds responsible for the antioxidant activity are not released to the culture medium; 
they are kept in the mycelium. Without exception, the mycelia and the culture media of S. 
bellinii gave better results than the same components of P. eryngii. 
Table 7.  Antioxidant activity (EC50 values, mg/mL extract) of the mycelia and culture media of P. eryngii and 
S. bellinii. The values corresponding to the fruiting body of both mushrooms (wild samples) are also presented. 
Values are given as mean±standard deviation 
 DPPH  
scavenging 
 activity 
Reducing  
power 
β-carotene 
 bleaching 
 inhibition 
TBARS  
formation  
inhibition 
Pleurotus eryngii 
Fruiting body (wild) 12.8±0.2 0.98±0.01 0.45±0.02 0.11±0.01 
iMMN liquid 
Mycelium 24.9±0.3b 1.35±0.02a 0.44±0.03c 0.17±0.01b 
Culture medium 28.2±0.5a 1.24±0.05b 0.57±0.01a 0.20±0.02a 
PDB 
Mycelium 19.7±0.5d 1.10±0.01c 0.40±0.05c 0.15±0.01c 
Culture medium 22.0±0.5c 0.95±0.02e 0.52±0.02b 0.17±0.01b 
iMMN solid Mycelium 17.1±0.5e 1.08±0.01c 0.23±0.01d 0.13±0.01d 
PDA Mycelium 16.1±0.5f 1.03±0.01d 0.18±0.02e 0.11±0.01e 
p-value (n = 54) 
Homoscedasticity1 0.015 <0.001 <0.001 <0.001 
1-way ANOVA2 <0.001 <0.001 <0.001 <0.001 
 
Suillus bellinii 
Fruiting body (wild) 0.61±0.01 0.16±0.01 0.12±0.01 0.011±0.001 
iMMN liquid 
Mycelium 1.10±0.01b 0.84±0.02b 0.21±0.03b 0.14±0.01a 
Culture medium 1.18±0.02a 0.93±0.02a 0.29±0.01a 0.15±0.01a 
PDB 
Mycelium 0.83±0.02d 0.24±0.01d 0.17±0.01d 0.010±0.001c 
Culture medium 0.95±0.03c 0.29±0.02c 0.20±0.01c 0.014±0.002bc 
iMMN solid Mycelium 0.62±0.03e 0.17±0.01e 0.14±0.02e 0.016±0.001b 
PDA Mycelium 0.59±0.02f 0.16±0.01e 0.14±0.01e 0.011±0.001c 
p-value (n = 54) 
Homoscedasticity1 0.003 <0.001 <0.001 <0.001 
1-way ANOVA2 <0.001 <0.001 <0.001 <0.001 
1Homoscedasticity among culture components was tested by the Levene test: homoscedasticity, p>0.05; 
heteroscedasticity, p<0.05. 2p<0.05 indicates that the mean value of at least one component differs from the 
others (in this case, multiple comparison tests were performed). For each culture component, means within a 
column with different letters differ significantly (p<0.05). Trolox EC50 values: 41.68±0.28 μg/ mL (DPPH 
scavenging activity), 41.43±1.27 μg/ mL (reducing power), 18.21±1.12 μg/ mL (β-carotene bleaching inhibition) 
and 22.84±0.74 μg/ mL (TBARS inhibition). 
In coherence with the observed for the fruiting bodies, the results obtained with P. eryngii 
mycelia were better than the reported previously, except for DPPH scavenging activity (Reis 
et al., 2012).  
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In general, the detected antioxidant activity represents an important added-value, despite the 
weaker performance of the mycelium and culture medium extracts when compared with the 
DPPH scavenging activity (EC50 values ranging from 0.8-3 mg/mL) and reducing power 
(EC50 = 0.5 mg/mL) obtained in polysaccharide fractions of P. eryngii (Li & Shah, 2014; Ma 
et al., 2016; Zhang et al., 2016). However, it should be reminded that the results presented 
herein were obtained with raw extracts, not with purified fractions.  
Due to the lack of studies with the mycelia of S. bellinii, no comparisons could be performed. 
4. Anti-inflammatory activity 
Macrophages, the main components of the innate immune system, have essential regulation 
functions in several immunopathological conditions during the inflammatory process (Yoon 
et al., 2009; Yuan et al., 2006). However, the overproduction of inﬂammatory mediators in 
the course of uncontrolled inﬂammation processes might cause adverse consequences in the 
pathogenesis of many inﬂammatory diseases such as cancer, diabetes and cardiovascular 
disease (Yuan et al., 2006). Endotoxin lipopolysaccharide (LPS) is able to induce the 
production of mediators like nitric oxide (NO), pro-inﬂammatory cytokines (besides 
inhibiting anti-inﬂammatory cytokines) and tumor necrosis factor in macrophages. Thereby, 
macrophages stimulated by LPS have been widely used for anti-inﬂammatory activities 
evaluation in vitro (García-Lafuente et al., 2009). In addition, due to reproducible response of 
RAW264.7 macrophages to LPS, this cell line has been widely used for inflammatory 
research (Huang & Ho, 2010).  
Accordingly, the anti-inflammatory activity was evaluated using a LPS-stimulated RAW264.7 
cell line (Table 8). The highest activity was measured in the methanolic extracts prepared 
from the fruiting bodies of S. bellinii (EC50 = 90 μg/mL extract). The extracts of P. eryngii 
fruiting bodies were also able to suppress NO production, but in less extent (EC50 = 223 
μg/mL extract). However, these results were better than those obtained in previous assays 
(Taofiq et al., 2015).  
Regarding the evaluated culture components, some interesting results were obtained, 
especially for the mycelia of P. eryngii grown in solid media, which showed higher anti-
inflammatory activity (EC50 = 184-189 μg/mL extract) than the corresponding fruiting bodies, 
highlighting their possible use in anti-inflammatory applications. 
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Moro et al., (2012) found that the phenolic compounds of the fruiting bodies might contribute 
to their anti-inflammatory activities, inducing inhibition of NO production and iNOS 
expression in LPS-activated RAW264.7 cells.  
Positive interactions could be observed between phenolic acids (in particular, p-
hydroxybenzoic acid) and anti-inflammatory effects of P. eyngii fruiting body and mycelia. It 
was observed that the extract with the highest anti-inflammatory activity showed the highest 
levels of phenolic acids and ergosterol. However, the anti-inflammatory activity of the 
mycelia of S. bellinii was not maintained in neither of the culture components, indicating that 
the anti-inflammatory effects of the extracts appeared to be related with other components 
besides ergosterol and phenolic acids. 
5. Cytotoxic activity 
The results for the anti-proliferative activity assayed in four human tumor cell lines (MCF-7, 
NCI-H460, HeLa and HepG2) and a porcine liver primary cell line (PLP2) are shown in 
Table 8.  
The extracts prepared from the fruiting bodies of wild S. bellinii samples showed higher 
activity against MCF7 (GI50 = 70 μg/mL extract), NCI-H460 (GI50 = 65 μg/mL extract) and 
HepG2 (GI50 = 68 μg/mL extract). However, the same extracts could not inhibit the HeLa cell 
line (up to the maximum assayed concentration: 400 μg/mL extract). On the other hand, the 
extracts from the fruiting bodies of wild P. eryngii samples had a similar behavior in all cell 
lines (GI50 values varying from 224 μg/mL extract in HepG2 to 246 μg/mL extract in MCF7). 
The anti-proliferative activity of P. eryngii extracts (specifically, its polysaccharides fraction) 
was previously reported in HepG2, where it induced apoptosis, cell cycle arrest at the S-phase 
and intracellular production of reactive oxygen species (Yang et al., 2013). Besides its in vitro 
anti-tumoral activity, P. eryngii was previously reported as being active against mice renal 
cancer in vivo (Yang et al., 2013). Despite their generally lower activity against tumor cell 
lines, the extracts from P. eryngii did not exhibit a toxic effect on the primary cell line, 
contrarily with the observed for S. bellinii fruiting bodies. 
Interestingly, none of the assayed culture components inhibit the growth of PLP2 cell line, 
which constitutes a good indicator of the lack of toxicity of the mycelia and culture media of 
both mushroom species in non-tumor cell lines.  
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Table 8. Anti-proliferative (GI50 values, μg/mL extract) and anti-inflammatory activity (EC50 values, μg/mL 
extract) of the mycelia and culture media of P. eryngii and S. bellinii. The values corresponding to the fruiting 
body of both mushrooms (wild samples) are also presented. Values are given as mean±standard deviation. 
 MCF-7 NCI-H460 HeLa HepG2 PLP2 RAW264.7 
Pleurotus eryngii 
Fruiting body (wild) 246±6 237±10 243±10 224±12 >400 223±9 
iMMN 
liquid 
Mycelium 242±7c 275±12cd 265±4d 280±3c >400 >400a 
Culture medium >400a >400a >400a >400a >400 >400a 
PDB 
Mycelium 270±15b 268±5d 280±1c 224±11d >400 308±10b 
Culture medium >400a >400a >400a >400a >400 >400a 
iMMN 
solid 
mycelium 
169±12d 363±13b 302±9b 314±2b >400 189±7c 
PDA mycelium 173±8d 285±10c 267±20d 140±6e >400 184±6c 
p-value 
(n = 54) 
Homoscedasticity <0.001 <0.001 <0.001 <0.001 - <0.001 
1-way ANOVA <0.001 <0.001 <0.001 <0.001 - <0.001 
 
Suillus bellinii 
Fruiting body (wild) 70±2 65±3 >400 68±3 215±38 90±2 
iMMN 
liquid 
Mycelium >400a >400a >400 >400a >400 >400 
Culture medium >400a >400a >400 >400a >400 >400 
PDB 
Mycelium 300±7b 279±2b >400 226±5b >400 >400 
Culture medium >400a >400a >400 >400a >400 >400 
iMMN 
solid 
Mycelium 
>400a >400a >400 >400a >400 >400 
PDA Mycelium 289±11c 257±2c >400 206±11c >400 >400 
p-value 
(n = 54) 
Homoscedasticity <0.001 <0.001 - <0.001 - - 
1-way ANOVA <0.001 <0.001 - <0.001 - - 
1Homoscedasticity among culture components was tested by the Levene test: homoscedasticity, p>0.05; 
heteroscedasticity, p<0.05. 2p<0.05 indicates that the mean value of at least one component differs from the 
others (in this case, multiple comparison tests were performed). For each culture component, means within a 
column with different letters differ significantly (p<0.05). Ellipticine GI50 value: 0.91±0.04 μg/mL (MCF-7), 
1.03±0.09 μg/mL (NCI-H460), 1.91±0.06 μg/mL (HeLa), 1.14±0.21 μg/mL (HepG2) and 3.22±0.67 μg /mL 
(PLP2). Dexamethaxone EC50 value: 15.70±1.1 μg/mL. 
Concerning the tumor cell lines, the mycelia of P. eryngii showed similar cytotoxicity to the 
fruiting bodies. In fact, the measured activity was often higher than the observed for the 
fruiting bodies. In some cases, such as the mycelium grown in PDA medium, the GI50 values 
are comparable to those obtained with purified polysaccharide fractions (Ma et al., 2014, 
2016; Ren et al., 2016), which represents a very interesting result.  
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On the other hand, the mycelia of S. bellinii showed significantly lower anti-proliferative 
activity, when compared to the fruiting bodies.  
The culture media did not show any anti-proliferative activity (up to the maximum assayed 
concentrations) in both mushroom species. 
P. eryngii samples that showed the highest cytotoxic activity have the highest content in 
phenolic acids and ergosterol.  
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CHAPTER 5.  CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
This study was initially designed to evaluate the mycelia of Pleurotus eryngii and Suillus 
bellinii, as well as their culture media, as potential alternative sources of bioactive compounds 
or as ingredients to be used in applications with antioxidant, anti-inflammatory or cytotoxic 
activities.  
According to the obtained results, we have demonstrated that the growth rate of mycelia 
depends on the culture media. Potato dextrose agar (PDA) media was the best one for P. 
eryngii, while incomplete Melin-Norkans medium (iMMN) solid media proved to be the best 
one for S. bellinii. Growth rate is not correlated with the biomass of mycelium; for instance, 
the produced biomass is similar in all culture media (except for the mycelia grown in PDB). 
For the chemical analysis, methanolic extracts showed several phenolic acids (p-
hydroxybenzoic acid, p-coumaric acid and protocatechuic acid), a related compound 
(cinnamic acid) and ergosterol, which have been suggested to play an important role in 
antioxidant, anti-inflammatory and anti-tumor activities. 
In general, S. bellinii mycelia showed higher contents of ergosterol (8.9-12.4 mg/g extract) 
and phenolic acids, mostly p-hydroxybenzoic acid (204-394 μg/g extract), which was also 
more abundant in the fruiting body of this species (1821 μg/g extract). Likewise, the 
antioxidant activity was also higher among the S. bellinii components with the highest activity 
being obtained on the TBARS formation inhibition assay (EC50 = 0.011 mg/mL extract). 
However, these extracts did not show anti-inflammatory activity up to the maximum assayed 
concentrations, contrarily to the observed for the mycelia of P. eryngii. Furthermore, the latter 
component showed a cytotoxicity similar (and often superior) to its fruiting bodies, in 
opposition to S. bellinii, whose mycelia showed a significant loss of anti-proliferative activity 
comparing to its fruiting bodies that revealed higher activity against MCF7 (GI50 = 70 μg/mL 
extract), NCI-H460 (GI50 = 65 μg/mL extract) and HepG2 (GI50 = 68 μg/mL extract). 
Therefore, it is difficult to assess which compounds are relevant for anti-inflammatory or anti-
tumor activities of the studied wild sample. 
In general, each culture component showed differentiated activity, which should be 
considered together with the growth rate and biomass yielded for each mushroom.   
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In vitro culture could be explored to obtain bioactive compounds from fruiting body used as 
unmodified natural products or in nutraceutical formulations with antioxidant, anti-
inflammatory and anti-tumor activities, as a possible food supplement or as an ingredient for 
industrial applications maintaining and promoting health and life quality. 
In this context, genomic, proteomic and metabolomic tools should be used to assist further in 
vitro cultivation in order to conclude about the most promising bioactive molecules to develop 
novel pharmaceutical products with a positive global impact on human healthcare but 
maintaining environmental preservation. 
The safety criteria of these compounds has been revealed by the absence of hepatotoxicity in 
porcine liver primary cells (PLP2), but in vivo models should be carried out in future steps.  
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